152 related articles for article (PubMed ID: 21268743)
1. Erythropoietin in kidney disease and type 2 diabetes.
Donnelly S
N Engl J Med; 2011 Jan; 364(4):385; author reply 385-6. PubMed ID: 21268743
[No Abstract] [Full Text] [Related]
2. Erythropoietin in kidney disease and type 2 diabetes.
Schnuelle P; Benck U; Krämer BK
N Engl J Med; 2011 Jan; 364(4):384; author reply 385-6. PubMed ID: 21268746
[No Abstract] [Full Text] [Related]
3. Erythropoietin in kidney disease and type 2 diabetes.
Thum T; Kalantar-Zadeh K; Anker SD
N Engl J Med; 2011 Jan; 364(4):384-5; author reply 385-6. PubMed ID: 21268744
[No Abstract] [Full Text] [Related]
4. Erythropoietin in kidney disease and type 2 diabetes.
Locatelli F; Del Vecchio L; Casartelli D
N Engl J Med; 2011 Jan; 364(4):384; author reply 385-6. PubMed ID: 21268745
[No Abstract] [Full Text] [Related]
5. Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
Solomon SD; Uno H; Lewis EF; Eckardt KU; Lin J; Burdmann EA; de Zeeuw D; Ivanovich P; Levey AS; Parfrey P; Remuzzi G; Singh AK; Toto R; Huang F; Rossert J; McMurray JJ; Pfeffer MA;
N Engl J Med; 2010 Sep; 363(12):1146-55. PubMed ID: 20843249
[TBL] [Abstract][Full Text] [Related]
6. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Pfeffer MA; Burdmann EA; Chen CY; Cooper ME; de Zeeuw D; Eckardt KU; Feyzi JM; Ivanovich P; Kewalramani R; Levey AS; Lewis EF; McGill JB; McMurray JJ; Parfrey P; Parving HH; Remuzzi G; Singh AK; Solomon SD; Toto R;
N Engl J Med; 2009 Nov; 361(21):2019-32. PubMed ID: 19880844
[TBL] [Abstract][Full Text] [Related]
7. Anemia: To TREAT or not to TREAT--that is the question.
Wiecek A
Nat Rev Nephrol; 2010 May; 6(5):254-5. PubMed ID: 20424627
[No Abstract] [Full Text] [Related]
8. Mitigating the cardiovascular risk of anemia in patients with type 2 diabetes and CKD: Does darbepoetin help? The TREAT Trial.
Hayes C; Alam A; Black-Peart J; McFarlane SI
Curr Diab Rep; 2010 Apr; 10(2):87-9. PubMed ID: 20425565
[No Abstract] [Full Text] [Related]
9. Managing anemia in patients with chronic kidney disease or cancer: development and role of darbepoetin alfa.
Scott SD
Pharmacotherapy; 2002 Sep; 22(9 Pt 2):129S-132S. PubMed ID: 12222582
[No Abstract] [Full Text] [Related]
10. Diabetes, anemia and CKD: Why TREAT?
Singh AK
Curr Diab Rep; 2010 Aug; 10(4):291-6. PubMed ID: 20544312
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological and clinical profiles of long-lasting erythropoiesis-stimulating agent (darbepoetin alfa; NESP].
Nagano N
Nihon Yakurigaku Zasshi; 2008 Apr; 131(4):291-9. PubMed ID: 18408341
[No Abstract] [Full Text] [Related]
12. No TREATment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease--safety warnings for erythropoiesis-stimulating agents.
Curtiss FR; Fairman KA
J Manag Care Pharm; 2009; 15(9):759-65. PubMed ID: 19954267
[No Abstract] [Full Text] [Related]
13. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
Li WY; Chu TS; Huang JW; Wu MS; Wu KD
J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153
[TBL] [Abstract][Full Text] [Related]
14. Prospective trials on anemia of chronic disease: the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).
Rao M; Pereira BJ
Kidney Int Suppl; 2003 Nov; (87):S12-9. PubMed ID: 14531768
[No Abstract] [Full Text] [Related]
15. Treatment of anemia in chronic kidney disease--strategies based on evidence.
Marsden PA
N Engl J Med; 2009 Nov; 361(21):2089-90. PubMed ID: 19880845
[No Abstract] [Full Text] [Related]
16. Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease.
Hudson JQ; Sameri RM
Pharmacotherapy; 2002 Sep; 22(9 Pt 2):141S-149S. PubMed ID: 12222584
[TBL] [Abstract][Full Text] [Related]
17. Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis.
Brown JN; Kemp DW; Brice KR
Pharmacotherapy; 2009 Apr; 29(4):468-72. PubMed ID: 19323622
[TBL] [Abstract][Full Text] [Related]
18. Darbepoetin alfa for treatment of anaemia in a case of chronic renal failure during pregnancy--case report.
Ghosh A; Ayers KJ
Clin Exp Obstet Gynecol; 2007; 34(3):193-4. PubMed ID: 17937101
[TBL] [Abstract][Full Text] [Related]
19. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
Chen HH; Tarng DC; Lee KF; Wu CY; Chen YC
J Nephrol; 2008; 21(4):543-9. PubMed ID: 18651544
[TBL] [Abstract][Full Text] [Related]
20. Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations from clinical studies.
Scott SD
Pharmacotherapy; 2002 Sep; 22(9 Pt 2):160S-165S. PubMed ID: 12222586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]